Preview: PAVmed's Earnings
Portfolio Pulse from Benzinga Insights
PAVmed Inc. (NASDAQ:PAVM) is scheduled to release its quarterly earnings report on March 26, 2024, with analysts expecting an EPS of $-1.89. The company's past earnings performance shows a mixed record of beating and missing EPS estimates, leading to varied stock price reactions. Shares of PAVmed have declined by 55.27% over the last 52 weeks, indicating a bearish sentiment among long-term shareholders. Investors will be keenly watching for the company's performance against the EPS estimate and any forward-looking guidance provided.
March 25, 2024 | 4:05 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
PAVmed Inc. is expected to announce its quarterly earnings with an anticipated EPS of $-1.89. The company's stock has seen a significant decline over the past year, indicating a bearish outlook among investors.
The anticipation of PAVmed's earnings report and its past performance suggest a cautious outlook. The expected EPS of $-1.89, combined with the stock's significant decline over the past year, reflects investor sentiment. However, the actual impact on the stock price will depend on whether the company meets or exceeds the EPS estimate and the nature of the guidance provided for future quarters.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100